INTRODUCTION
Fraser syndrome is a recessive multi-organ disorder characterized by 2 cryptophthalmos, syndactyly, renal agenesis, and other morphogenetic 3 defects [10] . The phenotypic similarities between Fraser syndrome patients 4 and mouse ''blebbing'' mutants suggested that the blebbing mutant mice 5 represented an animal model of Fraser syndrome [2] . In these blebbing 6 mutants, Grip1, Qbrick (also known as Frem1), Fras1, and Frem2 were 7 found to be disrupted [3, 8, 12, 13] . In Fraser syndrome patients, GRIP1, 8 FRAS1, and FREM2 mutations were also identified [3, 8, 14] , whereas 9 FREM1 (encoding human QBRICK) mutations were recently found in 1 expression pattern of FREM3 is distinct from other three 12 CSPG proteins; 2 while FRAS1, FREM1, and FREM2 are similar in their tissue expression 3 pattern and abundantly expressed in embryonic tissues, FREM3 expression 4 is low during embryonic period but high in several adult tissues such as skin, 5 salivary gland, and eye [4] . Despite structural resemblance between FREM3 6 and the other 12-CSPG proteins, no genetic disorder in which FREM3 is 7 ablated has been reported to date. In this study, to address this question, we 8 generated Frem3 mutant mice by CRISPR/Cas9-based genome editing and 9 investigated their phenotype. Frem3 mutant mice were generated by the CRISPR/Cas9 system as 10 described previously [6] . Superovulated B6D2F1 female mice were mated 11 with B6D2F1 males, and fertilized eggs were collected from their oviducts. 12 The pronuclear stage eggs were microinjected with 5 ng/l of pX330 plasmid, 
